№ lp_1_19905
File format: docx
Character count: 179394
File size: 1525 KB
Official professional guidance outlining the legal framework and governance arrangements for the prescribing, supply, administration, monitoring and disposal of controlled drugs in primary care settings in Scotland.
Year:
2023
Region:
Scotland
Jurisdiction:
Scotland
Topic:
Management of controlled drugs in primary care
Document type:
Guidance
Version:
3.0
Publication date:
April 2023
Issuing body:
Controlled Drugs Accountable Officers’ Network Scotland
Contributing organisation:
NHS Dumfries & Galloway
Foreword author:
Graeme Bryson
Author role:
Director of Pharmacy
Target audience:
Practitioners working within primary care
Legal framework referenced:
Misuse of Drugs Act 1971; Misuse of Drugs Regulations 2001; Controlled Drugs (Supervision of Management and Use) Regulations 2013
Scope:
Prescribing, supply, administration, storage, recording, monitoring and destruction of controlled drugs
Source type:
Official professional guidance
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.
The file will be delivered to the email address provided at checkout within 12 hours.
Don’t have cryptocurrency yet?
You can still complete your purchase in a few minutes:- Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
- In the app, tap Send.
- Select network, paste our wallet address.
- Send the exact amount shown above.
The final amount may vary slightly depending on the payment method.
The file will be sent to the email address provided at checkout within 24 hours.
The product description is provided for reference. Actual content and formatting may differ slightly.
Year:
2023
Note:
Region / City
Subject:
Billing Requirements for Drugs and Biologicals with Discarded Amounts
Document Type:
Policy
Organization / Institution:
SummaCare, Apex Summa Health Management Company, Summa Insurance Company
Target Audience:
Providers, Healthcare Administrators, Claims Department
Effective Period:
From 01/01/2017
Approval Date:
08/15/2023
Review Date:
Every 2 years or as necessary
Compliance Statement:
All members of the workforce are responsible for compliance with this policy.
Monitoring and Auditing:
Claims Department
Documentation Retention:
Minimum of 10 years
Purpose:
To outline the billing requirements for drugs and biologicals with unused and discarded amounts from single-dose containers or single-use packages.
Description:
Guidelines on proper billing procedures for drugs and biologicals, including the use of JW and JZ modifiers for discarded drug amounts or no wastage in single-dose vials, applicable to providers and insurers.
Year:
2025
Region / City:
Not specified
Theme:
Healthcare, Drug Coverage
Document Type:
Informational Flyer
Organization / Institution:
Wellcare
Author:
Not specified
Target Audience:
Healthcare providers, insurance plan members
Period of Validity:
Not specified
Approval Date:
07/24/2024
Date of Changes:
Not specified
Year:
2021
Region / City:
Australia
Theme:
Mental health, Alcohol and Other Drugs
Document Type:
Unit of competency
Organization / Institution:
Australian Skills Quality Authority (ASQA)
Author:
Not specified
Target Audience:
People working in community services, mental health and alcohol and other drug sectors
Period of validity:
Not specified
Approval Date:
Not specified
Date of modifications:
Release 2, Modification History: Release 2
Note:
Year
Topic:
Clinical Trial Agreement
Document Type:
Contract
Institution / Organization:
Istituto clinico Humanitas
Target Audience:
Medical, Scientific, and Research Professionals
Unit code:
CHCAOD007
Release:
2
Type:
Competency unit
Sector:
Health and community services
Target group:
Workers supporting people with alcohol and other drug challenges
Application:
Relapse prevention and management strategies
Legislation and standards:
Commonwealth and State/Territory legislation, Australian/New Zealand standards, industry codes of practice
Skills:
Relapse prevention planning, risk assessment, harm minimisation, communication, crisis management
Assessment:
Workplace demonstration or simulated environment, treatment plans, risk assessment tools
Knowledge:
Legal and ethical considerations, AOD effects and responses, relapse triggers, support strategies, therapy options, environmental and individual risk factors
Note:
Year
Topic:
Incident Reporting
Document Type:
Report Form
Organization:
NHS
Target Audience:
NHS Staff, Contractors
Year:
2023
Region / City:
Southwest London
Theme:
Pharmaceutical Offers, Medicines Access
Document Type:
Template
Organization / Institution:
Southwest London Integrated Care System (SWL ICS)
Author:
Southwest London ICS Pharmacy Team
Target Audience:
Healthcare Professionals, Pharmacists, Medical Staff
Action Period:
Ongoing
Approval Date:
2023-10-01
Amendment Date:
N/A
Contextual Description:
A template outlining procedures for Southwest London Trusts to request approval for commercial offers and deeply discounted medicines, including "Free of Charge" (FOC) schemes based on RMOC guidelines.
Year:
2012
Region / City:
Morgan County, Georgia
Topic:
Legal procedure, DUI test evidence
Document type:
Court brief
Organ / Institution:
Superior Court of Morgan County, Georgia
Author:
N/A
Target Audience:
Legal professionals, court officials
Period of validity:
N/A
Approval date:
N/A
Date of changes:
N/A
Year:
2019
Region / City:
Victoria, Australia
Topic:
Forensic Alcohol and Other Drugs (AOD) Treatment Services
Document Type:
Government Publication
Organization:
Victorian Government
Author:
Department of Health and Human Services (DHHS) and Department of Justice and Community Safety (DJCS)
Target Audience:
Service providers, professionals in the AOD and correctional sectors
Period of Validity:
Ongoing
Approval Date:
June 2019
Date of Changes:
Not specified
Year:
2017
Region / City:
United States
Theme:
Public Law, Pharmaceutical Pricing
Document Type:
Request for Modification
Organization / Institution:
U.S. Department of Veterans Affairs
Author:
Not specified
Target Audience:
Contractors in the pharmaceutical and medical supply industry
Effective Period:
January 15, 2017 or later
Approval Date:
November 2016
Amendment Date:
November 2016
Context:
A regulatory document outlining the procedures for modifying contracts related to pharmaceutical pricing under Public Law 102-585.
Year:
2023
Region / City:
Portland
Topic:
Clinical Research
Document Type:
Form
Author:
VA Portland Health Care System
Target Audience:
Researchers, Investigators, IRB Members
Period of Action:
Ongoing
Approval Date:
Not specified
Modification Date:
Not specified
Note:
Year
Topic:
Health, Pharmaceuticals
Document Type:
Informational Resource
Organization / Institution:
U.S. Food and Drug Administration
Target Audience:
Consumers, Healthcare Providers, Information Professionals, Researchers
Year:
2025
Region / City:
USA
Subject:
Medicare Part B Drugs and Biologicals ASP Data Reporting
Document Type:
Regulatory
Organization / Institution:
Centers for Medicare & Medicaid Services (CMS)
Author:
Centers for Medicare & Medicaid Services (CMS)
Target Audience:
Manufacturers of Medicare Part B Drugs and Biologicals
Period of Effect:
From January 1, 2022
Approval Date:
Not specified
Amendment Date:
November 5, 2025
Year:
2018
Region / city:
Victoria, Australia
Theme:
Environmental Impact Assessment, Offshore Gas and Condensate Production
Document Type:
Environmental Plan Summary
Organization / institution:
Cooper Energy
Author:
Cooper Energy
Target Audience:
Stakeholders, Environmental Regulators, Industry Professionals
Effective Period:
Ongoing (Operations and Maintenance Phase)
Approval Date:
April 30, 2018
Revision Date:
April 30, 2018
Year:
2023
Location:
Atlanta, GA, USA
Document Type:
Working Instructions / Inventory Form
Regulatory Authority:
Drug Enforcement Administration (DEA)
Author:
Joe Smith
Intended Audience:
DEA Registrants and laboratory staff
Inventory Scope:
Schedule I – II and Schedule III – V Controlled Substances
Inventory Date:
05/01/23
Inventory Time:
Beginning of Business (BOB) / Close of Business (COB)
Employees Conducting Inventory:
Joe Smith, Joann Taylor
Year:
2023
Region / City:
Atlanta, GA
Topic:
Controlled Substances Receiving Log
Document Type:
Instructional Form
Organization:
DEA
Author:
Not specified
Target Audience:
Registrants with DEA License
Period of Validity:
Not specified
Approval Date:
Not specified
Date of Changes:
Not specified
Note:
Department
Year:
2024
Region / City:
N/A
Topic:
Critical Appraisal
Document Type:
Checklist
Organization / Institution:
Critical Appraisal Skills Programme (CASP)
Author:
Critical Appraisal Skills Programme (CASP)
Target Audience:
Healthcare professionals, researchers
Date of Approval:
N/A
Date of Modification:
N/A